Search

Your search keyword '"Christina Kifnidi"' showing total 4 results
Start Over Author "Christina Kifnidi"
4 results on '"Christina Kifnidi"'

1. Sa1741 A REAL-WORLD COMPARISON OF THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF THERAPIES IN EARLY TREATMENT INITIATION WITH FIRST-LINE BIOLOGIC THERAPY IN ULCERATIVE COLITIS: RESULTS FROM EVOLVE

Author

Marielle Bassel, Chris Colby, Sumit Saha, Christian Agboton, Brian Bressler, Song Wang, Claudia G. Lopez, Christina Kifnidi, Neil R. Brett, Dirk Demuth, Uri Kopylov, Michelle Luo, Shashi Adsul, Andres Yarur, and Gerassimos J. Mantzaris

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, First line, Gastroenterology, medicine.disease, Ulcerative colitis, Vedolizumab, Internal medicine, medicine, Tumor necrosis factor alpha, business, medicine.drug
Published
2020
Full Text
View/download PDF

2. Mo1811 REAL-WORLD CLINICAL OUTCOMES OF BIOLOGIC-NAÏVE NONCOMPLICATED CROHN'S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: RESULTS FROM THE EVOLVE STUDY

Author

Christian Agboton, Shashi Adsul, Andres Yarur, Hankyul Kim, Sumit Saha, Neil R. Brett, Michelle Luo, Gerassimos J. Mantzaris, Claudia G. Lopez, Song Wang, Christina Kifnidi, Uri Kopylov, Brian Bressler, Marielle Bassel, and Dirk Demuth

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, business, medicine.disease, Vedolizumab, medicine.drug
Published
2020
Full Text
View/download PDF

3. Sa1748 CLINICAL EFFECTIVENESS AND SAFETY OF FIRST-LINE BIOLOGIC VEDOLIZUMAB AS A MONOTHERAPY OR COMBINATION THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY

Author

Chris Colby, Claudia G. Lopez, Christian Agboton, Brian Bressler, Sumit Saha, Uri Kopylov, Dirk Demuth, Marielle Bassel, Song Wang, Andres Yarur, Michelle Luo, Neil R. Brett, Christina Kifnidi, Gerassimos J. Mantzaris, and Shashi Adsul

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, Combination therapy, business.industry, Clinical effectiveness, First line, Gastroenterology, medicine.disease, Ulcerative colitis, Vedolizumab, Internal medicine, Medicine, business, medicine.drug
Published
2020
Full Text
View/download PDF

4. 638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease

Author

Gerassimos J. Mantzaris, Trevor Lissoos, Dirk Demuth, Neil R. Brett, Athanasios Natsios, Andres Yarur, Sumit Saha, Brian Bressler, Haridarshan Patel, Christina Kifnidi, Marielle Bassel, C Lopez, and Uri Kopylov

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Clinical effectiveness, Gastroenterology, medicine.disease, Ulcerative colitis, Discontinuation, Vedolizumab, Internal medicine, medicine, In patient, Tumor necrosis factor alpha, Anti-TNF therapy, business, medicine.drug
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results